This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Haapasalo, J. A. Articles by Haapasalo, H. K. Search for Related Content PubMed PubMed Citation Articles by Haapasalo, J. A. Articles by Haapasalo, H. K.

Expression of Carbonic Anhydrase IX in Astrocytic Tumors Predicts Poor Prognosis

Authors' Affiliations: ¹ Department of Pathology, Centre for Laboratory Medicine and ² Department of Neurology, Tampere University Hospital, ³ Institute of Medical Technology, University of Tampere and Tampere University Hospital, Tampere, Finland; ⁴ Department of Pathology, Oulu University Hospital, Oulu, Finland; ⁵ Faculty of Medicine, University of Turku, Turku, Finland, and ⁶ Centre for Molecular Medicine, Institute of Virology, Slovak Academy of Sciences, Bratislava, Slovak Republic

Requests for reprints: Hannu Haapasalo, Department of Pathology, Centre for Laboratory Medicine, Tampere University Hospital, P.O. Box 2000, FIN-33521 Tampere, Finland. Phone: 358-3-3117-6560; Fax: 358-3-3117-5503; E-mail: hannu.haapasalo{at}pshp.fi.

Purpose: Carbonic anhydrase IX (CA IX) is a hypoxia-inducible enzyme, which is associated with neoplastic growth. Ectopic CA IX expression has been observed in several tumors, whose normal counterparts do not express this enzyme. Normal human brain tissue shows only slight or no expression of CA IX.

Experimental Design: We describe CA IX expression in human diffusely infiltrating astrocytomas. The association of CA IX is evaluated with clinicopathologic and molecular factors including cell proliferation and apoptosis as well as the expression of p53 and epidermal growth factor receptor.

Results: CA IX immunopositivity was observed in 284 cases of 362 (78%) tumors. The positive areas were often located in close proximity to necrotic regions (P < 0.001). The CA IX immunoreactivity showed strong association with tumor malignancy grades (P < 0.0001). CA IX showed no association with p53 expression nor did it correlate with epidermal growth factor receptor–amplification, apoptosis, or cell proliferation. CA IX intensity had significant prognostic value in univariate (P=0.0011, log-rank test) and multivariate survival analysis (P = 0.038, Cox analysis).

Conclusions: CA IX expression is common in diffusely infiltrating high-grade astrocytomas. Our results suggest that CA IX is a useful biomarker for predicting poor prognosis of astrocytic tumors. It may also be a promising target molecule for the improvement of therapeutic interventions in astrocytomas.

This article has been cited by other articles:

				J. Haapasalo, M. Hilvo, K. Nordfors, H. Haapasalo, S. Parkkila, A. Hyrskyluoto, I. Rantala, A. Waheed, W. S. Sly, S. Pastorekova, et al. Identification of an alternatively spliced isoform of carbonic anhydrase XII in diffusely infiltrating astrocytic gliomas Neuro-oncol, April 1, 2008; 10(2): 131 - 138. [Abstract] [Full Text] [PDF]

				S. Sathornsumetee, Y. Cao, J. E. Marcello, J. E. Herndon II, R. E. McLendon, A. Desjardins, H. S. Friedman, M. W. Dewhirst, J. J. Vredenburgh, and J. N. Rich Tumor Angiogenic and Hypoxic Profiles Predict Radiographic Response and Survival in Malignant Astrocytoma Patients Treated With Bevacizumab and Irinotecan J. Clin. Oncol., January 10, 2008; 26(2): 271 - 278. [Abstract] [Full Text] [PDF]

				J. Haapasalo, K. Nordfors, S. Jarvela, H. Bragge, I. Rantala, A.-K. Parkkila, H. Haapasalo, and S. Parkkila Carbonic anhydrase II in the endothelium of glial tumors: A potential target for therapy Neuro-oncol, July 1, 2007; 9(3): 308 - 313. [Abstract] [Full Text] [PDF]

				D. Tripathy Capecitabine in Combination with Novel Targeted Agents in the Management of Metastatic Breast Cancer: Underlying Rationale and Results of Clinical Trials Oncologist, April 1, 2007; 12(4): 375 - 389. [Abstract] [Full Text] [PDF]

				H. Yoo, G. S. Baia, J. S. Smith, M. W. McDermott, A. W. Bollen, S. R. VandenBerg, K. R. Lamborn, and A. Lal Expression of the Hypoxia Marker Carbonic Anhydrase 9 Is Associated with Anaplastic Phenotypes in Meningiomas Clin. Cancer Res., January 1, 2007; 13(1): 68 - 75. [Abstract] [Full Text] [PDF]